{"id":827033,"date":"2025-03-18T10:16:37","date_gmt":"2025-03-18T14:16:37","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/"},"modified":"2025-03-18T10:16:37","modified_gmt":"2025-03-18T14:16:37","slug":"integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/","title":{"rendered":"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center"},"content":{"rendered":"<div class=\"xn-newslines\">\n<p class=\"xn-distributor\">PR Newswire<\/p>\n<\/p><\/div>\n<div class=\"xn-content\">\n<p>\n        <span class=\"legendSpanClass\">M\u00d6LNDAL,\u00a0Sweden<\/span>, <span class=\"legendSpanClass\"><span class=\"xn-chron\">March 18, 2025<\/span><\/span> \/PRNewswire\/ &#8212;<b>\u00a0Integrum AB (publ)<\/b> (Nasdaq First North Growth Market: INTEG B)<b> announces today that a newly published independent study from the Walter Reed National Military Medical Center in <span class=\"xn-location\">Bethesda, Maryland<\/span>, U.S., provides compelling evidence of OPRA<\/b><sup>\u2122<\/sup><b>\u00a0Implant System&#8217;s treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum&#8217;s innovative technology and its clinical benefit in patients who have undergone amputation.<\/b><\/p>\n<p>The two-year follow-up study (Level II Evidence) includes the latest and most advanced version of the OPRA<sup>\u2122<\/sup>\u00a0Implant System, which was introduced in 2017. The study results highlight several key benefits for patients using the implant system, including increased prosthetic use, improved mobility, and enhanced quality of life. Importantly, the study reveals improved outcomes compared to previously published data, including fewer infections and complications, and a 100% implant survival rate.<\/p>\n<p>&#8220;This study confirms the safety, durability, and positive impact of the OPRA Implant System for individuals who have undergone amputation. We are honored to support the men and women who have served their country and are excited to see growing evidence supporting its role in improving mobility and overall well-being for amputees globally,&#8221; comments <span class=\"xn-person\">Scott Flora<\/span>, acting CEO of Integrum.<\/p>\n<p>Collectively, the insights gathered from this study will be useful in driving further adoption of the technology by US health providers, as well as to increase the awareness of the OPRA\u2122\u00a0Implant System among health professionals and potential patients.<\/p>\n<p>&#8220;We need high quality prospective clinical trials like this to confirm not only the benefits of transdermal bone anchored implants, but also the complication profile over the long-term.\u00a0By further proving safety and effectiveness of The OPRA Implant System, we hope this growing body of evidence will encourage exponential acceptance among US insurance providers for reimbursement, making this life-changing technology more accessible to patients in need,&#8221; Dr. <span class=\"xn-person\">Jonathan Forsberg<\/span>, MD, PhD currently practicing at Memorial Sloan Kettering in <span class=\"xn-location\">New York<\/span>, retired from the military after 32 years of service.<\/p>\n<p>&#8220;We were excited to see that our results further confirmed the benefits of direct skeletal attachment for improving function and quality of life for patient with limb loss, while maintaining better than expected infection and major complication rates,&#8221;\u00a0says Dr. <span class=\"xn-person\">Benjamin K. Potter<\/span>, MD, currently Chair, Department of Orthopaedic Surgery at Penn Medicine in <span class=\"xn-location\">Philadelphia, PA.<\/span> Dr. Potter retired from the Army after over 22 years of service.<\/p>\n<p>The study was authored by\u00a0Benjamin K. Potter, MD, <span class=\"xn-person\">Jonathan A. Forsberg<\/span>, MD, PhD, LCDR Ashley B. Anderson, MD, <span class=\"xn-person\">Jason M. Souza<\/span>, MD, and <span class=\"xn-person\">Julio Rivera<\/span>, PhD, and recently published in Clinical Orthopaedics and Related Research (CORR).<\/p>\n<p>Read the full article: <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4385708-1&amp;h=2082807726&amp;u=https%3A%2F%2Fjournals.lww.com%2Fclinorthop%2Fabstract%2F2025%2F03000%2Fwhat_functional_outcomes_can_be_expected_with.24.aspx&amp;a=https%3A%2F%2Fjournals.lww.com%2Fclinorthop%2Fabstract%2F2025%2F03000%2Fwhat_functional_outcomes_can_be_expected_with.24.aspx\" target=\"_blank\" rel=\"nofollow\">https:\/\/journals.lww.com\/clinorthop\/abstract\/2025\/03000\/what_functional_outcomes_can_be_expected_with.24.aspx<\/a>.<\/p>\n<p>\n        <b>For more information, please contact:<\/b><br \/>\n        <br \/>J\u00f6rgen Svanstr\u00f6m, CFO<br \/>Phone: + 46 (0) 70\u00a0734 96 60<br \/>E-mail: <a href=\"mailto:Jorgen.svanstrom@integrum.se\" target=\"_blank\" rel=\"nofollow\">Jorgen.svanstrom@integrum.se<\/a><\/p>\n<p>\n        <b>Certified Adviser<\/b><br \/>\n        <br \/>Carnegie Investment Bank AB (publ) is Certified Adviser.<\/p>\n<p>This information was brought to you by Cision <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4385708-1&amp;h=92934315&amp;u=http%3A%2F%2Fnews.cision.com%2F&amp;a=http%3A%2F%2Fnews.cision.com\" target=\"_blank\" rel=\"nofollow\">http:\/\/news.cision.com<\/a><\/p>\n<p>\n        <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4385708-1&amp;h=3298037685&amp;u=https%3A%2F%2Fnews.cision.com%2Fintegrum-ab%2Fr%2Fintegrum-s-opra-tm--implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-st%2Cc4120587&amp;a=https%3A%2F%2Fnews.cision.com%2Fintegrum-ab%2Fr%2Fintegrum-s-opra-tm--implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-st%2Cc4120587\" target=\"_blank\" rel=\"nofollow\">https:\/\/news.cision.com\/integrum-ab\/r\/integrum-s-opra-tm&#8211;implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-st,c4120587<\/a>\n      <\/p>\n<p>The following files are available for download:<\/p>\n<div>\n<table border=\"0\" cellspacing=\"0\" cellpadding=\"1\">\n<tr>\n<td class=\"prngen1\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\"><br \/>\n                  <a href=\"https:\/\/c212.net\/c\/link\/?t=0&amp;l=en&amp;o=4385708-1&amp;h=8492943&amp;u=https%3A%2F%2Fmb.cision.com%2FPublic%2F17531%2F4120587%2Fb0c62df5fe2c8cbf.pdf&amp;a=https%3A%2F%2Fmb.cision.com%2FPublic%2F17531%2F4120587%2Fb0c62df5fe2c8cbf.pdf\" target=\"_blank\" class=\"prnews_a\" rel=\"nofollow\">https:\/\/mb.cision.com\/Public\/17531\/4120587\/b0c62df5fe2c8cbf.pdf<\/a><br \/>\n                <\/span>\n              <\/p>\n<\/td>\n<td class=\"prngen1\" colspan=\"1\" rowspan=\"1\">\n<p class=\"prnml4\">\n                <span class=\"prnews_span\">Integrum PR TFAOS 2025-03-18 eng<\/span>\n              <\/p>\n<\/td>\n<\/tr>\n<\/table><\/div>\n<p>\u00a0<\/p>\n<p id=\"PURL\">\n        <img loading=\"lazy\" decoding=\"async\" title=\"Cision\" width=\"12\" height=\"12\" alt=\"Cision\" src=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18\" \/> View original content:<a id=\"PRNURL\" rel=\"nofollow\" href=\"https:\/\/www.prnewswire.com\/news-releases\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center-302404635.html\" target=\"_blank\">https:\/\/www.prnewswire.com\/news-releases\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center-302404635.html<\/a><\/p>\n<p>SOURCE  Integrum AB<\/p>\n<\/p><\/div>\n<p>    <img decoding=\"async\" alt=\"\" src=\"https:\/\/rt.prnewswire.com\/rt.gif?NewsItemId=IO43874&amp;Transmission_Id=202503181013PR_NEWS_USPR_____IO43874&amp;DateId=20250318\" style=\"border:0px;width:1px;height:1px\" \/><\/p>\n","protected":false},"excerpt":{"rendered":"<p>PR Newswire M\u00d6LNDAL,\u00a0Sweden, March 18, 2025 \/PRNewswire\/ &#8212;\u00a0Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA\u2122\u00a0Implant System&#8217;s treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum&#8217;s innovative technology and its clinical benefit in patients who have undergone amputation. The two-year follow-up study (Level II Evidence) includes the latest and most advanced version of the OPRA\u2122\u00a0Implant System, which was introduced in 2017. The study results highlight several key benefits for patients using the implant system, including increased prosthetic use, improved mobility, and enhanced quality &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-827033","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Integrum&#039;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Integrum&#039;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"PR Newswire M\u00d6LNDAL,\u00a0Sweden, March 18, 2025 \/PRNewswire\/ &#8212;\u00a0Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA\u2122\u00a0Implant System&#8217;s treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum&#8217;s innovative technology and its clinical benefit in patients who have undergone amputation. The two-year follow-up study (Level II Evidence) includes the latest and most advanced version of the OPRA\u2122\u00a0Implant System, which was introduced in 2017. The study results highlight several key benefits for patients using the implant system, including increased prosthetic use, improved mobility, and enhanced quality &hellip; Continue reading &quot;Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-03-18T14:16:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center\",\"datePublished\":\"2025-03-18T14:16:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/\"},\"wordCount\":557,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO43874&amp;sd=2025-03-18\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/\",\"name\":\"Integrum's OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO43874&amp;sd=2025-03-18\",\"datePublished\":\"2025-03-18T14:16:37+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#primaryimage\",\"url\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO43874&amp;sd=2025-03-18\",\"contentUrl\":\"https:\\\/\\\/c212.net\\\/c\\\/img\\\/favicon.png?sn=IO43874&amp;sd=2025-03-18\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Integrum's OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/","og_locale":"en_US","og_type":"article","og_title":"Integrum's OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk","og_description":"PR Newswire M\u00d6LNDAL,\u00a0Sweden, March 18, 2025 \/PRNewswire\/ &#8212;\u00a0Integrum AB (publ) (Nasdaq First North Growth Market: INTEG B) announces today that a newly published independent study from the Walter Reed National Military Medical Center in Bethesda, Maryland, U.S., provides compelling evidence of OPRA\u2122\u00a0Implant System&#8217;s treatment effectiveness in transfemoral amputees. The study demonstrates significant functional improvements over traditional socket prostheses, an important validation of Integrum&#8217;s innovative technology and its clinical benefit in patients who have undergone amputation. The two-year follow-up study (Level II Evidence) includes the latest and most advanced version of the OPRA\u2122\u00a0Implant System, which was introduced in 2017. The study results highlight several key benefits for patients using the implant system, including increased prosthetic use, improved mobility, and enhanced quality &hellip; Continue reading \"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/","og_site_name":"Market Newsdesk","article_published_time":"2025-03-18T14:16:37+00:00","og_image":[{"url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center","datePublished":"2025-03-18T14:16:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/"},"wordCount":557,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/","name":"Integrum's OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#primaryimage"},"thumbnailUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18","datePublished":"2025-03-18T14:16:37+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#primaryimage","url":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18","contentUrl":"https:\/\/c212.net\/c\/img\/favicon.png?sn=IO43874&amp;sd=2025-03-18"},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/integrums-opra-implant-system-demonstrates-superior-treatment-outcomes-in-two-year-follow-up-study-by-walter-reed-national-military-medical-center\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Integrum&#8217;s OPRA\u2122 Implant System demonstrates superior treatment outcomes in two-year follow-up study by Walter Reed National Military Medical Center"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/827033","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=827033"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/827033\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=827033"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=827033"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=827033"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}